KOL Engagement · SolveLetter #1

How to Increase Expert (KOL) Engagement in Congresses, Conferences, and Seminars?

YP
Yakov Pakhomov, MD, PhD
February 2025 8 min read

The engagement crisis at congresses

Something has changed at medical congresses. Attendance at satellite symposia is declining. Expert speakers report smaller, less engaged audiences. Poster sessions that once generated hours of corridor discussion now see visitors scanning QR codes and moving on within seconds.

The problem is not that physicians have lost interest in science. It’s that the formats we use to deliver scientific content at congresses have not evolved to match how modern clinicians consume and process information. We’re applying 1990s presentation models to 2025 attention patterns.

Key observation: Average time spent at a pharma satellite symposium has dropped from 45 minutes in 2019 to approximately 25 minutes in 2024 — and the proportion of attendees who stay for the full session has fallen below 40%.

Why traditional formats fail

The standard congress engagement model — invite a KOL, prepare 60 slides, present for 40 minutes, allow 10 minutes for Q&A — has fundamental design flaws:

  • Passive consumption. Sitting in a dark room watching slides activates the least effective mode of learning. Without active participation, retention drops below 20% within 48 hours.
  • One-directional flow. The expert talks, the audience listens. There is no mechanism for capturing what the audience actually needs to learn versus what the company wants to communicate.
  • Competition for attention. At major congresses like ASCO or ESMO, attendees face 50+ satellite events. Without a compelling reason to stay, they will leave for the next session.
  • Undifferentiated content. When every company uses the same format, the only differentiator is the speaker’s charisma — which is an unreliable variable.

Interactive formats that actually work

Over the past three years, we’ve tested and refined several alternative formats that consistently outperform traditional symposia in engagement metrics:

Case-based workshops

Instead of presenting data, present clinical cases that require the audience to make decisions using the available evidence. Use live polling to capture treatment choices, then reveal the data that supports or challenges those choices. This format transforms passive listeners into active problem-solvers.

Expert debate format

Two experts with genuinely different perspectives on a clinical question debate in a structured format. The audience votes before and after the debate. The shift in opinion becomes the key metric — and the scientific tension holds attention far better than consensus presentations.

Evidence challenge sessions

Present your product’s evidence alongside competitor data. Invite the audience to identify strengths and weaknesses of each dataset. This approach requires confidence in your data — but it builds credibility and trust far more effectively than one-sided presentations.

FormatEngagement rateAvg. session completionPost-event recall at 30 days
Traditional symposium35–45%55%15–20%
Case-based workshop70–80%85%40–50%
Expert debate60–75%78%35–45%
Evidence challenge65–80%82%45–55%

Digital and hybrid solutions

Technology can amplify engagement when used to solve specific problems — not as a gimmick:

  • Live polling and sentiment tracking — tools like Slido or Mentimeter capture real-time audience perspectives. The data itself becomes part of the scientific discussion.
  • Pre-congress digital briefings — sending a 5-minute video summary of key data before the congress allows the live session to focus on implications and debate rather than data review.
  • Post-congress follow-up programs — extending the conversation beyond the event with structured digital touchpoints: a clinical case series, a data visualization, or a moderated online discussion forum.
  • AI-powered content personalization — using attendee specialty and interest data to deliver customized pre-reads and post-event summaries.

The congress event is not the goal. It is the catalyst. The real engagement happens in the weeks before and after — if you design for it.

— Yakov Pakhomov, Medical Director, MAG

Measuring expert engagement: beyond attendance

Counting seats filled is the least useful engagement metric. We recommend tracking:

  1. Active participation rate — what percentage of attendees interacted (asked questions, voted, contributed to discussions)?
  2. Session completion rate — what proportion stayed for the full session versus leaving early?
  3. Content interaction depth — for digital components, did attendees open materials, spend time on them, or merely glance?
  4. Follow-up engagement — did attendees accept post-event communication, request materials, or engage with follow-up programs?
  5. Sentiment shift — did the event change perceptions, knowledge, or treatment intentions? Pre/post surveys with the same questions measure this directly.

Building long-term KOL relationships

A congress event is one touchpoint in a multi-year relationship. The most effective KOL engagement strategies treat each event as part of a continuous program:

  • Map the relationship lifecycle. Where is each expert in their engagement journey — new contact, occasional advisor, or deep collaborator?
  • Diversify touchpoints. Beyond congresses: advisory boards, publication collaborations, educational initiatives, research partnerships.
  • Respect their time. Experts who feel that every interaction delivers value will prioritize your events. Experts who feel used will disengage.
  • Close the feedback loop. Share how their input was used. Experts who see their advisory board recommendations reflected in the company’s strategy become the strongest advocates.

Result: Companies that implement structured, multi-touchpoint KOL programs report 2.5× higher expert retention rates and significantly stronger advocacy for their evidence narratives.

Newsletter
Get SolveLetter monthly in your inbox
Evidence strategy, advisory board insights, AI tools, and regulatory updates — curated for pharma medical affairs teams.
1–2 articles per month, never more
Practical insights from real projects
Free forever, unsubscribe anytime
Subscribe to SolveLetter
Join 1,200+ pharma professionals. No spam.
Evidence Scanner
Evidence ScannerTM
AI infrastructure

AI-powered.
Expert-validated.

We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.

Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Advisory board transcription + structured AI summary
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
Evidence Scanner · Monitoring module
// Weekly digest: GLP-1 RA publications
monitor("GLP-1 receptor agonist", {
  frequency: "weekly",
  sources: ["pubmed", "congress_abstracts"]
})
Scanning 12 sources...
Weekly Digest · Feb 24–Mar 2
7 new publications found. 2 RCTs, 3 RWE studies, 2 meta-analyses. Key finding: MACE benefit confirmed in CVOT pooled analysis...